Nashat Amir's Form 4 filing
Camp4 Therapeutics Corp (CAMP) · filed Oct 15, 2024
- Accession no.
- 0001104659-24-108703
- Filed
- Oct 15, 2024
- Trade date
- Oct 15, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market purchases total $10.0M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nashat AmirCIK 0001575843 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | CConversionAcquired | +1,250,061 | –F1 | – | 1,250,061 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionAcquired | +87,448 | –F1 | – | 87,448 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionAcquired | +353,718 | –F4 | – | 1,603,779 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionAcquired | +24,745 | –F4 | – | 112,193 | Indirect | |
| Oct 15, 2024 | Common Stock | PPurchaseAcquired | +909,090 | $11.00 | +$9,999,990 | 909,090 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | CConversionDisposed | −1,250,061 | –F1 | – | 0 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionDisposed | −87,448 | –F1 | – | 0 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionDisposed | −353,718 | –F4 | – | 0 | Indirect | |
| Oct 15, 2024 | Common Stock | CConversionDisposed | −24,745 | –F4 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
- F4
On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
Remarks
PP X's purchase of the Issuer's common stock was also reported on a Form 3 filed by PPGP X, PP X and the PPGP X Managing Members on the date hereof.